Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 13 Rectal Neoplasms 10 Esophageal Neoplasms 7 Colorectal Neoplasms 7 Stomach Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Uterine Cervical Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Adenocarcinoma Of Esophagus 5 Squamous Cell Carcinoma of Head and Neck 4 Neuroblastoma 4 Neoplasm Metastasis 4 Nasopharyngeal Carcinoma 4 Colonic Neoplasms 4 Sarcoma 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Liposarcoma 3 Inflammatory Breast Neoplasms 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Prostatic Neoplasms 2 Peritoneal Neoplasms 2 Ovarian Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Multiple Myeloma 2 Melanoma 2 Hemangiosarcoma 2 Hemangiopericytoma, Malignant 2

Interventions

Gemcitabine 13 Cisplatin 10 Capecitabine 7 pembrolizumab 3 Oxaliplatin 3 Leucovorin 3 Chemotherapy, Adjuvant 3 durvalumab 2 Watchful Waiting 2 Fluorouracil 2 Dihematoporphyrin Ether 2 zanidatamab 1 becatecarin 1 Tegafur 1 Taxes 1 Somatostatin 1 S 1 (combination) 1 Platinum 1 Phototherapy 1 Photochemotherapy 1 Ondansetron 1 Neoadjuvant Therapy 1 Laser Therapy 1 Irinotecan 1 Folfox protocol 1 Fentanyl 1 Escitalopram 1 Epirubicin 1 Dexamethasone 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Gallbladder Neoplasms × Neoadjuvant Therapy × Clear all

NCT06712420 2025-04-16

NEOGB

Rajiv Gandhi Cancer Institute & Research Center, India

Phase 3 Recruiting

Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡